- Home
- OABI vs BZAI Comparison
OABI vs BZAI Comparison
Compare OABI & BZAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- BZAI
- Stock Information
- Founded
- OABI 2012
- BZAI 2010
- Country
- OABI United States
- BZAI United States
- Employees
- OABI N/A
- BZAI N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- BZAI
- Sector
- OABI Health Care
- BZAI
- Exchange
- OABI Nasdaq
- BZAI Nasdaq
- Market Cap
- OABI 198.2M
- BZAI 206.4M
- IPO Year
- OABI N/A
- BZAI N/A
- Fundamental
- Price
- OABI $2.18
- BZAI $2.93
- Analyst Decision
- OABI Strong Buy
- BZAI Buy
- Analyst Count
- OABI 3
- BZAI 2
- Target Price
- OABI $7.00
- BZAI $6.50
- AVG Volume (30 Days)
- OABI 854.4K
- BZAI 454.8K
- Earning Date
- OABI 08-07-2025
- BZAI 08-15-2025
- Dividend Yield
- OABI N/A
- BZAI N/A
- EPS Growth
- OABI N/A
- BZAI N/A
- EPS
- OABI N/A
- BZAI N/A
- Revenue
- OABI $26,744,000.00
- BZAI $2,012,000.00
- Revenue This Year
- OABI N/A
- BZAI $1,504.31
- Revenue Next Year
- OABI $45.65
- BZAI $372.18
- P/E Ratio
- OABI N/A
- BZAI N/A
- Revenue Growth
- OABI 27.07
- BZAI N/A
- 52 Week Low
- OABI $1.22
- BZAI $1.70
- 52 Week High
- OABI $4.96
- BZAI $29.61
- Technical
- Relative Strength Index (RSI)
- OABI 72.48
- BZAI N/A
- Support Level
- OABI $1.79
- BZAI N/A
- Resistance Level
- OABI $1.73
- BZAI N/A
- Average True Range (ATR)
- OABI 0.11
- BZAI 0.00
- MACD
- OABI 0.04
- BZAI 0.00
- Stochastic Oscillator
- OABI 93.97
- BZAI 0.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About BZAI Blaize Holdings Inc. Common Stock
Blaize Holdings Inc provides customized, programmable processor architecture suite, artificial intelligence (AI)-enabled edge computing solutions. The company is a semiconductor and software technology company dedicated to revolutionizing the world of AI.